Hematology

简称 HEMATOLOGY ·ENGLAND ·出版周期 Bimonthly ·年均收录 89 篇

1.6

最新影响因子

3.10%

自引率

容易

投稿难度

偏慢,4-8周

审稿周期

期刊简介

Hematology是一本专注于血液学领域的国际学术期刊，ISSN号为1024-5332，由英国出版商Taylor & Francis出版，出版地为英国，出版周期为每年一期。该期刊的影响因子根据最新数据约为2.0左右，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学领域的3区或4区。Hematology的发文特点集中于血液疾病的基础与临床研究，涵盖白血病、淋巴瘤、贫血、造血干细胞移植以及血液免疫学等方向，旨在推动血液学领域的学术交流与技术进步。该期刊的质量较为稳定，但影响因子相对较低，可能反映其学术影响力有限；投稿时需注意审稿周期和接受率，以确保研究成果的及时发表。总体而言，Hematology适合血液学领域的研究者投稿，尤其关注临床与转化医学的研究。

影响因子趋势

近期发表

Human platelet 5-hydroxyindoleacetic acid concentrations are meager and unlikely to be physiologically active or play a role in inflammation 2026-09-18

Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system 2026-09-15

Impact of defibrotide on survival in sinusoidal obstruction syndrome / veno-occlusive disease: a retrospective cohort study comparing two sequential treatment eras 2026-09-10

Frontline therapies for adult patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia: a systematic literature review 2026-09-09

Beyond antigen matching: compatibility intelligence theory for transfusion as an emergent biological system 2026-09-07

Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications 2026-09-05

Serologic follow-up in patients with multiple myeloma without repeated bone marrow studies: a single-institution experience 2026-09-02

Integrative bioinformatic analysis delineates a mitochondrial-hematopoietic gene signature for diagnosis and immune characterization in myelodysplastic syndromes 2026-09-03

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience 2026-09-01

Clinical and genetic features of Ph-negative myeloproliferative neoplasms with dual-driver gene positivity 2026-09-01